Page last updated: 2024-11-06

zopiclone and Liver Diseases

zopiclone has been researched along with Liver Diseases in 2 studies

zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.

Liver Diseases: Pathological processes of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" The carrier of hypnotic activity is the parent compound; however, knowledge of its metabolic profile is essential for the understanding of pharmacokinetic changes in various pathophysiological conditions."1.27Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. ( Dreyfus, JF; Gaillot, J; Houghton, GW; Le Roux, Y, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parker, G1
Roberts, CJ1
Gaillot, J1
Le Roux, Y1
Houghton, GW1
Dreyfus, JF1

Other Studies

2 other studies available for zopiclone and Liver Diseases

ArticleYear
Plasma concentrations and central nervous system effects of the new hypnotic agent zopiclone in patients with chronic liver disease.
    British journal of clinical pharmacology, 1983, Volume: 16, Issue:3

    Topics: Adult; Aged; Azabicyclo Compounds; Central Nervous System Depressants; Chronic Disease; Electroencep

1983
Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency.
    Sleep, 1987, Volume: 10 Suppl 1

    Topics: Adult; Age Factors; Aged; Animals; Azabicyclo Compounds; Biological Availability; Dogs; Half-Life; H

1987